Here’s what we know about the new Covid-19 variant ‘Eris’

NEW YORK – The World Health Organization (WHO) on Aug 9 flagged a new Covid-19 variant that’s spreading quickly and widely. Nicknamed “Eris” and officially designated EG.5, the new offshoot is rapidly gaining ground across the world. It’s still of low concern, according to the WHO, and other factors may explain a current rise in hospitalizations in a number of countries, including the US.

1. What is EG.5?

Eris is a descendant of a group of coronavirus strains labeled XBB. These are all offshoots of the Omicron variant, which arose in late 2021. EG.5 made up an estimated 17.4 per cent of global cases in the week ending July 23, according to the WHO, up from only 7.6 per cent four weeks earlier. It’s growing quickly in the US, where it recently became the most common strain, according to estimates by the Centers for Disease Control and Prevention (CDC). 

2. How concerning is it?

Eris poses a low risk to global public health, the WHO said. Although it’s growing in prevalence in comparison with other strains and appears to be better at evading the body’s immune defenses, there’s no evidence it causes more severe disease than other versions of the coronavirus. For its part, the CDC has said there’s no evidence it’s able to spread more easily than its predecessors. Existing vaccines and treatments are expected to remain effective against it. Since it’s closely related to the XBB family, that includes updated booster shots targeting those strains that will soon be available. 

3. What symptoms does it cause? 

The symptoms seem to be the same as those caused by other strains, said Mr Thomas Russo, chief of the Division of Infectious Diseases at the University of Buffalo’s medical school, in an email. Common ones include a runny nose, headache, fatigue, a sore throat and sneezing. People who are older, have compromised immune systems or suffer from multiple other conditions are at higher risk for more severe effects. These may include lower respiratory disease, chest pain and shortness of breath. The virus still kills hundreds of people each week in the US, so it’s important to get tested if you think you may be infected.

4. What’s causing a rise in US hospitalizations?

The number of people admitted to the hospital with Covid-19 is on the rise for the first time this year in the US, and wastewater data has also shown cases ticking up. There’s no evidence linking rising hospitalizations in multiple countries to new strains, the WHO says, and experts have pointed to other likely culprits. Extreme heat is driving gatherings indoors, where the coronavirus spreads more easily. Also, with the pandemic over, people are traveling again and no longer wearing masks. And for many people, it’s been months since they last got a vaccine or contracted the virus, meaning their immunity against infection is waning. 

5. Is the US prepared for a rise in Covid-19?

The US has scaled back its response to Covid-19 in recent months. The government no longer purchases vaccines and treatments for the public and free tests aren’t as widely available. Still, experts say the US isn’t likely to see the kind of surge in cases that upended life in the early years of the pandemic. Because of vaccination and prior infections, the population has widespread protection from severe disease, and therapies like Pfizer Inc.’s Paxlovid antiviral drug can reduce the risk of hospitalization and death if they’re taken early on. Even after recent increases, hospital admissions are lower than at at any other point since at least August 2020, according to CDC data.

6. What can you do to protect yourself?

New booster vaccines will be available in the fall, and experts say they’re especially important for vulnerable people. If you’re at higher risk and you’re going to be in a situation where exposure is likely, such as a large gathering, Russo says you can consider getting a booster shot of one of the older vaccines that are already on the market. In any case, masks help protect against infection. Pharmacies still offer Covid-19 testing services and sell at-home tests. If you’re at high risk and you develop symptoms, a test can help determine whether you should start taking Paxlovid.

BLOOMBERG

Source